Mode
Text Size
Log in / Sign up

avatrombopag

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of avatrombopag

6 trials tracked of avatrombopag: 3 in phase 3 or 4 and 3 with published results. The most-cited published study has 220 citations.

6Trials tracked
3Phase 3 & 4
0Recruiting
3With published results
Phase distribution
Phase 3 3 Phase 2 3
  1. Phase 3 Efficacy and Safety of Oral E5501 Plus Standard of Care for the Treatment of Thrombocytopenia in Adults With Chronic Immune Thrombocytopenia (Amendment 02) Completed · 220 cited
  2. Phase 3 Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Active Non-Hematological Cancers Completed · 90 cited
  3. Phase 3 Avatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects With Immune Thrombocytopenia for ≥6 Months Completed · 8 cited
  4. Phase 2 A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Once-daily Oral Avatrombopag in Japanese Subjects With Chronic Liver Diseases and Thrombocytopenia Completed
  5. Phase 2 Chronic Hepatitis C Virus Related Thrombocytopenia to Evaluate the Effects of E5501 Completed
  6. Phase 2 Once-Daily Oral Avatrombopag Tablets Used in Subjects With Chronic Liver Diseases and Thrombocytopenia Prior to Elective Surgical or Diagnostic Procedures Completed

Showing the 6 most-cited and recently-updated of 6 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.